⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for primary amyloidosis

Every month we try and update this database with for primary amyloidosis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Trial of Treatment With Lenalidomide-Melphalan-Dexamethasone in Patients With Primary (AL) AmyloidosisNCT00883623
Primary Amyloid...
Lenalidomide
18 Years - 74 YearsHeidelberg University
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom BurdenNCT00651937
Multiple Myelom...
Primary Amyloid...
Melphalan
Stem Cell Infus...
Questionnaires
Granulocyte-col...
Apheresis
60 Years - M.D. Anderson Cancer Center
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisNCT02555969
Amyloidosis
Primary Amyloid...
- Tufts Medical Center
Minimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisNCT02555969
Amyloidosis
Primary Amyloid...
- Tufts Medical Center
Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) AmyloidosisNCT01707264
Primary Amyloid...
NEOD001
18 Years - Prothena Biosciences Ltd.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: